Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Theresa A. Urban"'
Autor:
Kelly J. Gaffney, Theresa A. Urban, Mariana Lucena, Lisa Rybicki, Navneet S. Majhail, Sherif Beniameen Mossad
Publikováno v:
Clinical Hematology International.
Background Our institution has used trimethoprim-sulfamethoxazole (TMP-SMX) as the antibacterial agent of choice for infection prophylaxis during the pre-engraftment period in the allogeneic transplant (allo-HCT) population. Methods This retrospectiv
Autor:
Kelly J Gaffney, Theresa A Urban, Mariana Lucena, Faiz Anwer, Robert M Dean, Aaron T Gerds, Betty K Hamilton, Deepa Jagadeesh, Matt E Kalaycio, Jack Khouri, Brad Pohlman, Ronald Sobecks, Allison Winter, Lisa Rybicki, Navneet S Majhail, Brian T Hill
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Busulfan-based conditioning regimens are associated with serious toxicities and literature reports increased risk of toxicities when daily area under the curve concentrations exceed 6000 µM-minute. We implemented real time pharmacokinetic-guided the
Autor:
Ronald Sobecks, Brian T. Hill, Lisa Rybicki, Brian J. Bolwell, Mariana Lucena, Matt Kalaycio, Navneet S. Majhail, Edward A. Copelan, Deepa Jagadeesh, Betty K. Hamilton, Brad Pohlman, Aaron T. Gerds, Theresa A. Urban, Robert M. Dean
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:262-271
Optimal administration of busulfan (Bu) is hampered by variable and unpredictable drug metabolism in individual patients. At our institution, Bu was previously administered with fixed weight-based dosing (WBD) in combination with cyclophosphamide (Cy
Autor:
Betty K. Hamilton, Mariana Lucena, Navneet S. Majhail, Kelly Gaffney, Christina Ferraro, Theresa A. Urban
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S364-S365
Long-term survivors of allogeneic hematopoietic cell transplantation (HCT) are at greater risk for developing late effects, with increased risk of mortality compared to the general population. This includes a 2-3 fold increased risk of metabolic synd
Autor:
Matt Kalaycio, Faiz Anwer, Jack Khouri, Brian T. Hill, Robert M. Dean, Allison M. Winter, Ronald Sobecks, Navneet S. Majhail, Kelly Gaffney, Betty K. Hamilton, Lisa Rybicki, Deepa Jagadeesh, Theresa A. Urban, Mariana Lucena, Brad Pohlman, Aaron T. Gerds
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S388-S389
Background Busulfan (Bu) based conditioning regimens are associated with serious toxicities including myelosuppression, hepatotoxicity, and sinusoidal obstructive syndrome (SOS). Previous literature reports increased risk of toxicities when the daily
Autor:
Betty K. Hamilton, Matt Kalaycio, Mariana Lucena, Kelly Gaffney, Deepa Jagadeesh, Theresa A. Urban, Ronald Sobecks, Navneet S. Majhail, Robert M. Dean, Brad Pohlman, Aaron T. Gerds, Brian T. Hill, Faiz Anwer
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S93
Background Pharmacists are increasingly identified as vital members of the HSCT multidisciplinary team. At our institution, pharmacists recently established roles providing clinical pharmacy services in the outpatient setting focused on performing in
Autor:
Navneet S. Majhail, Christina Ferraro, Theresa A. Urban, Mariana Lucena, Kelly Gaffney, Betty K. Hamilton, Chad L. Deal
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S77
Bone density loss is a well-recognized and common complication in allogeneic HCT recipients. Guidelines recommend screening with dual photon densitometry at 1 year post-HCT, and counseling of patients on preventative strategies along with considerati
Autor:
Lisa Rybicki, Navneet S. Majhail, Theresa A. Urban, Brad Pohlman, Aaron T. Gerds, Edward A. Copelan, Brian T. Hill, Ronald Sobecks, Brian J. Bolwell, Mariana Lucerna, Betty K. Hamilton, Deepa Jagadeesh, Matt Kalaycio, Robert M. Dean
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S31-S32
Introduction Busulfan (Bu) is integral to many preparative regimens for hematopoietic stem cell transplantation but its metabolism is variable and unpredictable. At our institution, Bu was administered with fixed weight-based dosing (WBD) for NHL pat
Autor:
Robert M. Dean, Betty K. Hamilton, Navneet S. Majhail, Theresa A. Urban, Mariana Lucena, Deepa Jagadeesh, Ronald Sobecks, Kelly Gaffney, Matt Kalaycio, Lisa Rybicki, Brad Pohlman, Aaron T. Gerds, Brian T. Hill
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S277-S278
Background BuCyVP and BEAM are two commonly used conditioning regimens for AHCT. Previous literature has reported improved outcomes with BEAM compared to BuCyVP in Hodgkin lymphoma (HL) patients, although results in non-Hodgkin lymphoma (NHL) patient
Autor:
Hien Liu, Lisa Rybicki, Julie Coffman, Navneet S. Majhail, Brian T. Hill, Sheila Serafino, Laura Bernhard, Matt Kalaycio, Betty K. Hamilton, Theresa A. Urban, Jessica El-Asmar, Donna Corrigan, Ronald Sobecks, Brad Pohlman, Aaron T. Gerds, Deepa Jagadeesh, Robert M. Dean
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:S285-S286